ClearKone® Prescribed to More than 16,000 Patients in 32 Countries

CARLSBAD, Calif., July 22, 2011 — SynergEyes, Inc., the leader in hybrid contact lens technology, announced that ClearKone®, its second generation hybrid contact lens for irregular corneas, has been prescribed to more than 16,000 patients in 32 countries since the lens became available in la…

Vitamin B2 Eye Drops and Low Dose Ultraviolet May Cure Keratoconus

MCHENRY, Ill., March 29, 2011 — A potentially blinding disease called keratoconus may now be stopped and even reversed with a new process applying vitamin B2 eye drops and low-dose ultraviolet light to the diseased eye. The first FDA-monitored clinical trial in Illinois of what is called “…

ClearKone(TM) by SynergEyes(R) Awarded Most Innovative New Product of 2009

CARLSBAD, Calif., Dec. 21, 2009 — CONNECT(R), one of the nation’s most successful organizations dedicated to creating and sustaining the growth of innovative technology and life science businesses, announced SynergEyes, Inc., the high Dk hybrid contact lens manufacturer, as the winn…